£80.64

Humana Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£81 today · previous high £81 · all-time low £80

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£80.64 £79.86 £80.03 £80.20 £80.37 £80.54 £80.71 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
71 days 19 days · current 0 18 36 53 71 £80 £81 Days at Price

Price Analysis

Most common price: £80 (71 days, 78.9%)

Price range: £80 - £81

Price levels: 2 different prices over 90 days

Description

Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
19 November 2010
Listed Since
11 July 2010

Barcode

No barcode data available

Similar Products You Might Like

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
96% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£40.30 04 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
84% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 17 May 2026
Antifolate Drugs in Cancer Therapy (Cancer Drug Discovery and Development)
82% match

Antifolate Drugs in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£146.04 18 May 2026
Molecular Pathogenesis of Colorectal Cancer
82% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£110.54 18 May 2026
Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)
82% match

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)

Humana

£80.65 11 May 2026
Management of Colorectal Cancers in Older People
81% match

Management of Colorectal Cancers in Older People

Springer

£80.64 17 May 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
81% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£77.90 18 May 2026
Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment
81% match

Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment

Humana

£77.50 18 May 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
81% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.05 18 May 2026
Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications
80% match

Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications

Springer

£136.92 18 May 2026
Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)
80% match

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Humana

£107.98 18 May 2026
Cancer-Targeted Drug Delivery (Methods in Pharmacology and Toxicology)
80% match

Cancer-Targeted Drug Delivery (Methods in Pharmacology and Toxicology)

Humana

£98.00 17 May 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
80% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£107.98 18 May 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
79% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£142.42 18 May 2026
Colorectal Cancer: Prevention, Diagnosis and Treatment
79% match

Colorectal Cancer: Prevention, Diagnosis and Treatment

£55.55 18 May 2026
Complexities in Colorectal Surgery: Decision-Making and Management
79% match

Complexities in Colorectal Surgery: Decision-Making and Management

Springer

£89.12 17 May 2026
Tumor Dormancy and Recurrence (Cancer Drug Discovery and Development)
79% match

Tumor Dormancy and Recurrence (Cancer Drug Discovery and Development)

Humana

£72.42 18 May 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
78% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£107.57 18 May 2026
Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)
78% match

Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)

Springer

£85.52 18 May 2026
Causes and Control of Colorectal Cancer: A Model for Cancer Prevention: 78 (Developments in Oncology, 78)
78% match

Causes and Control of Colorectal Cancer: A Model for Cancer Prevention: 78 (Developments in Oncology, 78)

Springer

£149.38 18 May 2026
Colorectal Cancer
78% match

Colorectal Cancer

IntechOpen

£111.35 04 May 2026
Genetics of Colorectal Cancer (Cancer Genetics)
78% match

Genetics of Colorectal Cancer (Cancer Genetics)

Springer

£107.98 18 May 2026
In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)
78% match

In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£80.65 11 May 2026
Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
77% match

Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£107.98 18 May 2026